We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+13.63%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$48.3B
AUM Growth
+$4.2B
Cap. Flow
-$749M
Cap. Flow %
-1.55%
Top 10 Hldgs %
25.22%
Holding
973
New
114
Increased
273
Reduced
385
Closed
131

Sector Composition

Rank Sector Weight
1 Technology 25.57%
2 Healthcare 16.39%
3 Financials 11.55%
4 Consumer Discretionary 10.38%
5 Industrials 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGR icon
126
Progressive
PGR
$123B
$90.5M 0.19%
568,285
+6,300
+1% +$986K
BX icon
127
Blackstone
BX
$109B
$90.4M 0.19%
690,200
-15,500
-2% -$1.68M
PLD icon
128
Prologis
PLD
$131B
$90.2M 0.19%
676,514
-282,600
-29% -$32.1M
AMAT icon
129
Applied Materials
AMAT
$429B
$90.2M 0.19%
556,288
-27,400
-5% -$4.03M
MET icon
130
MetLife
MET
$62.1B
$89.5M 0.19%
1,353,926
+825,900
+156% +$51.7M
EQIX icon
131
Equinix
EQIX
$104B
$89.5M 0.19%
111,168
-16,900
-13% -$13M
LHX icon
132
L3Harris
LHX
$53.2B
$89.4M 0.19%
424,359
+236,300
+126% +$44.3M
MDLZ icon
133
Mondelez International
MDLZ
$79.8B
$86.8M 0.18%
1,197,997
-372,400
-24% -$25.5M
BHVN icon
134
Biohaven
BHVN
$2.05B
$86.5M 0.18%
2,020,644
+778,569
+63% +$24.2M
NVO
135
Novo Nordisk
NVO
$197B
$84.2M 0.17%
814,392
-544,212
-40% -$53.8M
VICI icon
136
VICI Properties
VICI
$29B
$83.8M 0.17%
2,629,900
+397,300
+18% +$11.7M
HCA icon
137
HCA Healthcare
HCA
$88.7B
$83M 0.17%
306,619
+106,519
+53% +$26.3M
ADP icon
138
Automatic Data Processing
ADP
$107B
$81.4M 0.17%
349,476
+4,900
+1% +$1.14M
CVS icon
139
CVS Health
CVS
$128B
$80.4M 0.17%
1,018,061
-443,444
-30% -$31.6M
ELV icon
140
Elevance Health
ELV
$84.9B
$79.6M 0.16%
168,867
-39,553
-19% -$18.3M
TMUS icon
141
T-Mobile US
TMUS
$186B
$79.2M 0.16%
494,234
-20,400
-4% -$3.02M
AIG icon
142
American International
AIG
$42.4B
$79.1M 0.16%
1,166,938
-890,900
-43% -$56.8M
NOG icon
143
Northern Oil and Gas
NOG
$2.18B
$78.3M 0.16%
2,112,361
+666,844
+46% +$25.2M
PANW icon
144
Palo Alto Networks
PANW
$298B
$75.2M 0.16%
509,800
-184,400
-27% -$24.7M
CABA icon
145
Cabaletta Bio
CABA
$442M
$74.2M 0.15%
3,266,645
CME icon
146
CME Group
CME
$94.9B
$73.6M 0.15%
349,631
-8,000
-2% -$1.71M
SLNO
147
DELISTED
Soleno Therapeutics
SLNO
$73.5M 0.15%
1,826,814
+499,814
+38% +$14.2M
SNPS icon
148
Synopsys
SNPS
$77.1B
$73.4M 0.15%
142,523
+2,400
+2% +$1.23M
CDNS icon
149
Cadence Design Systems
CDNS
$92.6B
$72M 0.15%
264,300
+3,100
+1% +$799K
GPCR icon
150
Structure Therapeutics
GPCR
$3.55B
$71.6M 0.15%
1,756,918
-43,005
-2% -$2.46M

Similar funds

Adage Capital Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Adage Capital Partners held 973 positions worth $48.3B, up 9.5% from $44.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Adage Capital Partners's Q4 2023 filing shows 114 new, 273 increased, 385 reduced and 131 closed positions. Its largest new stake was Uber: 2,148,900 shares worth $132M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $340M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q4 2023 buy was Uber: 2,148,900 shares worth $132M.
  • Adage Capital Partners added most to Hess in Q4 2023, an estimated $516M increase.
  • Adage Capital Partners's biggest Q4 2023 reduction was lululemon athletica, cutting an estimated $124M.
  • Adage Capital Partners fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $340M.
  • Adage Capital Partners's ten largest holdings make up 25% of its $48.3B portfolio in Q4 2023.
  • Adage Capital Partners opened 114 new positions and closed 131 in Q4 2023.
  • Adage Capital Partners's portfolio value rose 9.5% quarter-over-quarter to $48.3B.

Based on Adage Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.